AT466026T - Derivatives of GLP-1 and exendin with prolonged duration of action profile - Google Patents

Derivatives of GLP-1 and exendin with prolonged duration of action profile

Info

Publication number
AT466026T
AT466026T AT99936077T AT99936077T AT466026T AT 466026 T AT466026 T AT 466026T AT 99936077 T AT99936077 T AT 99936077T AT 99936077 T AT99936077 T AT 99936077T AT 466026 T AT466026 T AT 466026T
Authority
AT
Austria
Prior art keywords
exendin
glp
derivatives
prolonged duration
action profile
Prior art date
Application number
AT99936077T
Other languages
German (de)
Inventor
Liselotte Knudsen
Per Huusfeldt
Per Nielsen
Kjeld Madsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK27498 priority Critical
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to PCT/DK1999/000086 priority patent/WO1999043708A1/en
Publication of AT466026T publication Critical patent/AT466026T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57563Vasoactive intestinal peptide [VIP]; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AT99936077T 1998-02-27 1999-02-25 Derivatives of GLP-1 and exendin with prolonged duration of action profile AT466026T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK27498 1998-02-27
PCT/DK1999/000086 WO1999043708A1 (en) 1998-02-27 1999-02-25 Glp-1 derivatives of glp-1 and exendin with protracted profile of action

Publications (1)

Publication Number Publication Date
AT466026T true AT466026T (en) 2010-05-15

Family

ID=8091706

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936077T AT466026T (en) 1998-02-27 1999-02-25 Derivatives of GLP-1 and exendin with prolonged duration of action profile

Country Status (4)

Country Link
EP (1) EP1840134B1 (en)
AT (1) AT466026T (en)
DE (1) DE69942305D1 (en)
ZA (1) ZA9901571B (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202B1 (en) 1985-03-28 1990-11-27 Cetus Corp
US5614492A (en) * 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
CA1341320C (en) 1986-05-05 2001-11-20 Joel Habener Insulinotropic hormone
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
EP0464022B1 (en) * 1989-03-20 2000-05-31 The General Hospital Corporation Insulinotropic hormone
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
DK36392D0 (en) 1992-03-19 1992-03-19 Novo Nordisk As Use of the chemical compound
DK36492D0 (en) 1992-03-19 1992-03-19 Novo Nordisk As Preparation
US5424286A (en) 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
CN1183158C (en) 1996-06-05 2005-01-05 罗赫诊断器材股份有限公司 Exendin analogue, processes for their preparation and medicaments containing them
DE122009000079I2 (en) * 1996-08-30 2011-06-16 Novo Nordisk As Novo Alle GLP-1 derivatives

Also Published As

Publication number Publication date
EP1840134A2 (en) 2007-10-03
ZA9901571B (en) 1999-09-02
EP1840134A3 (en) 2008-01-23
DE69942305D1 (en) 2010-06-10
EP1840134B1 (en) 2016-04-13

Similar Documents

Publication Publication Date Title
DE69826007D1 (en) Tetrafluoroethylene copolymer and its use
DE69942306D1 (en) analog descendants of glp-1
DE69720243D1 (en) Chemical modification of biomedical materials with genipin
DE69631376D1 (en) Substituted liposaccaride useful in the treatment and prevention of endotoxemia
DE60029446D1 (en) Arylthiazolidinedione and aryloxa zolidinedion derivatives
DK0635261T3 (en) Coated microparticles with improved drug absorption
DE69825251D1 (en) Polarizer and flüssikristallanzeigeelement
DK1366725T3 (en) Ablationsinstrument with more electrodes
DE69913128D1 (en) Partly blockverschachtelte cdma-encoding and decoding
DE60021541D1 (en) Production of hochloeslichen and stable mineralstoffergaenzungen
EE03231B1 (en) Tetracyclic derivatives, their preparation and the use of
DE69734149D1 (en) Cinoline derivatives and use as remedies
NO20000996L (en) Combination therapy comprising atorvastatin and an antihypertensive agent
EE200000468A (en) The compounds, their use and pharmaceutical composition,
DE69722397D1 (en) Insulin derivatives and their use
DE69826683D1 (en) Therapeutic compositions containing amlodipine and atorvastatin
DE59905858D1 (en) Use of pit-emulsions
DE60030669D1 (en) Structural elements and associated parts
DE69814069D1 (en) New form of s-omeprazole
EE200100223A (en) Interferon-beta fusion proteins and their use
DE69832971D1 (en) Non-kugliges and non-flaky pyrithione-salt
EE200100480A (en) Xenon use in the treatment of nerve poisoning
DE69727149D1 (en) Variants of vascular endothelzellwachsumsfaktors with antagonistic effect
DE69920497D1 (en) Liponsaürederivate and their use in the treatment of diseases
NO20000292D0 (en) Formulations with hoeyt content ammoniumglyfosfat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties